Peter Luppa
Overview
Explore the profile of Peter Luppa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tintu A, Buno Soto A, Van Hoof V, Bench S, Malpass A, Schilling U, et al.
Clin Chem Lab Med
. 2024 May;
62(11):2169-2176.
PMID: 38726766
Objectives: This study aimed to evaluate discrepancies in potassium measurements between point-of-care testing (POCT) and central laboratory (CL) methods, focusing on the impact of hemolysis on these measurements and its...
2.
Schaller S, Fuest K, Ulm B, Schmid S, Bubb C, Eckstein H, et al.
Ann Surg
. 2023 Jul;
279(3):402-409.
PMID: 37477023
Objective: To investigate whether goal-directed albumin substitution during surgery and postanesthesia care to maintain a serum albumin concentration >30 g/L can reduce postoperative complications. Background: Hypoalbuminemia is associated with numerous...
3.
Krueger K, Mayer Z, Kottmaier M, Gerckens M, Boeck S, Luppa P, et al.
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289796
The interaction between programmed death-1 receptor PD-1 and its ligands PD-L1 and PD-L2 is involved in self-tolerance, immune escape of cancer, cardiovascular diseases, and COVID-19. As blood-based protein markers they...
4.
Krueger K, Mayer Z, Gerckens M, Boeck S, Luppa P, Holdenrieder S
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289665
Programmed death-1 receptor PD-1(CD279) and its corresponding ligands PD-L1(CD274, B7-H1) and PD-L2(CD273, B7-DC) play important roles in physiological immune tolerance and for immune escape in cancer disease. Hence, the establishment...
5.
Lorenz G, Shen Y, Hausinger R, Scheid C, Eckermann M, Hornung S, et al.
Sci Rep
. 2022 Sep;
12(1):16419.
PMID: 36180564
Extended cut-off filtration by medium cut-off membranes (MCO) has been shown to be safe in maintenance hemodialysis (HD). The notion of using them for the control of chronic low-grade inflammation...
6.
Lahmer T, Erber J, Schmid R, Schneider J, Spinner C, Luppa P, et al.
Multidiscip Respir Med
. 2022 Jun;
17:825.
PMID: 35646346
The relationship between SARS-CoV-2 quantitative viral load and risk of disease progression, morbidity such as long- COVID or mortality in immunosuppressed, remains largely undefined in COVID-19 patients. Critically ill immunosuppressed...
7.
Erber J, Wiessner J, Huberle C, Schneider J, Mijocevic H, von Bomhard D, et al.
Transfus Apher Sci
. 2021 Sep;
60(6):103278.
PMID: 34548246
Objective: To investigate the effect of convalescent plasma therapy (CPT) on clinical courses of B-cell-sufficient and B-cell-depleted patients with life-threatening COVID-19. Patients And Methods: In this case series, we retrospectively...
8.
Schaller S, Fuest K, Ulm B, Schmid S, Bubb C, von Eisenhart-Rothe R, et al.
Trials
. 2020 Aug;
21(1):726.
PMID: 32811539
Background: Hypalbuminemia is associated with numerous postoperative complications, so a perioperative albumin substitution is often considered. The objective of SuperAdd is to investigate whether substitution of human albumin, aiming to...
9.
Pfob C, Eiber M, Luppa P, Maurer F, Maurer T, Tauber R, et al.
EJNMMI Res
. 2018 Mar;
8(1):17.
PMID: 29488080
Background: Amino acid co-infusion for renal protection in endoradiotherapy (ERT) applied as prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) or peptide receptor radionuclide therapy (PRRT) has been shown to cause...
10.
Noe S, von Werder A, Iakoubov R, Schneider H, Thaler M, Luppa P, et al.
Exp Clin Endocrinol Diabetes
. 2016 Oct;
125(1):53-56.
PMID: 27750352
To investigate the kinetics of adrenocorticotropin (ACTH) following oral metyrapone administration and describe differences between ACTH-deficient and non-ACTH-deficient subjects. Patients from a tertiary endocrine center at a University Hospital in...